Smartleaf Asset Management
LEGN icon

Smartleaf Asset Management’s Legend Biotech LEGN Stock Holding History

Smartleaf Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$94 Buy
+5
New +$107 ﹤0.01% 3544
2024
Q4 		– Sell
-21
Closed -$1.03K – 2973
2024
Q3 		$1.03K Buy
+21
New +$1.12K ﹤0.01% 2651

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Matthews International Capital Management
Matthews International Capital Management San Francisco, California $241M AUM 42.66% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
IAMH
IvyRock Asset Management (HK) Sheung Wan, Hong Kong $190M AUM 21.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Empire Life Investments
Empire Life Investments Toronto, Ontario, Canada $1.83B AUM 33.18% 1-Year Est. Return

Smartleaf Asset Management's LEGN Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Legend Biotech (LEGN) in Q3 2026: 5 shares worth $94. The stake represents ﹤0.01% of the portfolio and ranks #3544 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in LEGN as recently as Q3 2024.

Smartleaf Asset Management first reported a position in LEGN in Q3 2024 and has held it in 2 quarters since. The position peaked at $1.03K in Q3 2024. 98 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Smartleaf Asset Management held 5 shares of Legend Biotech worth $94 as of Q3 2026.
  • Legend Biotech was a new Smartleaf Asset Management position in Q3 2026.
  • Legend Biotech made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3544 holding.
  • Smartleaf Asset Management first reported a position in Legend Biotech in Q3 2024 and has held it in 2 quarters since.
  • Smartleaf Asset Management's Legend Biotech position peaked at $1.03K in Q3 2024.
  • 98 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.